These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 22843154)

  • 21. Home blood pressure (BP) monitoring in kidney transplant recipients is more adequate to monitor BP than office BP.
    Agena F; Prado Edos S; Souza PS; da Silva GV; Lemos FB; Mion D; Nahas WC; David-Neto E
    Nephrol Dial Transplant; 2011 Nov; 26(11):3745-9. PubMed ID: 21441398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Home blood pressure is as reliable as ambulatory blood pressure in predicting target-organ damage in hypertension.
    Stergiou GS; Argyraki KK; Moyssakis I; Mastorantonakis SE; Achimastos AD; Karamanos VG; Roussias LG
    Am J Hypertens; 2007 Jun; 20(6):616-21. PubMed ID: 17531917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypertension in chronic kidney disease: the influence of renal transplantation.
    Azancot MA; Ramos N; Moreso FJ; Ibernon M; Espinel E; Torres IB; Fort J; Seron D
    Transplantation; 2014 Sep; 98(5):537-42. PubMed ID: 24770618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of ambulatory blood pressure and the heart rate profile with renal function parameters in hypertensive patients with chronic kidney disease.
    Kanaoka T; Tamura K; Ohsawa M; Yanagi M; Haku S; Wakui H; Maeda A; Dejima T; Azushima K; Mitsuhashi H; Okano Y; Fujikawa T; Toya Y; Mizushima S; Tochikubo O; Umemura S
    Clin Exp Hypertens; 2012; 34(4):264-9. PubMed ID: 22578052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of hypertension control in chronic kidney disease patients by ambulatory blood pressure monitoring.
    Prakash S; Chibber SK; Prakash S; Pande DP; Joshi S; Gupta KK; Rana DS
    J Assoc Physicians India; 2005 Sep; 53():769-74. PubMed ID: 16334620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of circadian blood pressure variation in chronic kidney disease.
    Agarwal R; Kariyanna SS; Light RP
    Am J Nephrol; 2009; 30(6):547-53. PubMed ID: 19844086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Masked Hypertension and Elevated Nighttime Blood Pressure in CKD: Prevalence and Association with Target Organ Damage.
    Drawz PE; Alper AB; Anderson AH; Brecklin CS; Charleston J; Chen J; Deo R; Fischer MJ; He J; Hsu CY; Huan Y; Keane MG; Kusek JW; Makos GK; Miller ER; Soliman EZ; Steigerwalt SP; Taliercio JJ; Townsend RR; Weir MR; Wright JT; Xie D; Rahman M;
    Clin J Am Soc Nephrol; 2016 Apr; 11(4):642-52. PubMed ID: 26912547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: a cross-sectional analysis of a 20,000-patient database in Spain.
    Gorostidi M; Sobrino J; Segura J; Sierra C; de la Sierra A; Hernández del Rey R; Vinyoles E; Galcerán JM; López-Eady MD; Marín R; Banegas JR; Sarría A; Coca A; Ruilope LM;
    J Hypertens; 2007 May; 25(5):977-84. PubMed ID: 17414661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of 24-h ambulatory blood pressure measurement in a routine clinical setting of patients with chronic renal disease.
    Jacob P; Hartung R; Bohlender J; Stein G
    J Hum Hypertens; 2004 Oct; 18(10):745-51. PubMed ID: 15103314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal observations on circadian blood pressure variation in chronic kidney disease stages 3-5.
    Elung-Jensen T; Strandgaard S; Kamper AL
    Nephrol Dial Transplant; 2008 Sep; 23(9):2873-8. PubMed ID: 18353888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What should be the goal blood pressure in nondiabetic chronic kidney disease?
    Schneider MP; Hilgers KF
    Curr Opin Nephrol Hypertens; 2014 Mar; 23(2):180-5. PubMed ID: 24401787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Office and 24-hour ambulatory blood pressure measurements in hypertension assessment in children with chronic kidney disease].
    Łątka M; Drożdż T; Kwinta P; Dąbrowska E; Pietrzyk JA; Drożdż D
    Przegl Lek; 2016; 73(5):287-95. PubMed ID: 29629741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disparate assessment of clinic blood pressure and ambulatory blood pressure in differently aged patients with chronic kidney disease.
    Wang C; Gong WY; Zhang J; Peng H; Tang H; Liu X; Ye ZC; Lou T
    Int J Cardiol; 2015 Mar; 183():54-62. PubMed ID: 25662054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study.
    Hermida RC
    Chronobiol Int; 2007; 24(4):749-75. PubMed ID: 17701685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Superior consistency of ambulatory blood pressure monitoring in children: implications for clinical trials.
    Gimpel C; Wühl E; Arbeiter K; Drozdz D; Trivelli A; Charbit M; Gellermann J; Dusek J; Jankauskiene A; Emre S; Schaefer F;
    J Hypertens; 2009 Aug; 27(8):1568-74. PubMed ID: 19550356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypertension diagnosis and prognosis in chronic kidney disease with out-of-office blood pressure monitoring.
    Agarwal R
    Curr Opin Nephrol Hypertens; 2006 May; 15(3):309-13. PubMed ID: 16609300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
    Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G
    G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of ambulatory blood pressure.
    Imai Y
    Blood Press Monit; 1999 Oct; 4(5):249-56. PubMed ID: 10547646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for the management of blood pressure in CKD.
    Ruzicka M; Quinn RR; McFarlane P; Hemmelgarn B; Ramesh Prasad GV; Feber J; Nesrallah G; MacKinnon M; Tangri N; McCormick B; Tobe S; Blydt-Hansen TD; Hiremath S
    Am J Kidney Dis; 2014 Jun; 63(6):869-87. PubMed ID: 24725980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.